← Back to patent-cliff list
PIPE-505
Tier C — Watch / tradePIPE-505
Contineum Therapeutics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：Amyloid precursor protein secretases
Indications (approved)：神经性听力损失
Regional status
US
No progress
2020-10-15
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of PIPE-505?
Approved indications include: 神经性听力损失.
When does the PIPE-505 patent expire?
No public expiry year is available for PIPE-505 yet; this page updates once verified.
How do I get a quote for PIPE-505 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21